Abstract
Hemophilia A is the most common X-linked bleeding disorder; it is caused by deficiency of coagulation factor VIII (FVIII). Replacement therapy with rFVIII produced from human cell line is a major goal for treating hemophilia patients. We prepared a full-length recombinant FVIII (FVIII-FL), using the pMFG-P140K retroviral vector. The IRES DNA fragment was cloned upstream to the P140K gene, providing a 9.34-kb bicistronic vector. FVIII-FL cDNA was then cloned upstream to IRES, resulting in a 16.6-kb construct. In parallel, an eGFP control vector was generated, resulting in a 10.1- kb construct. The 293T cells were transfected with these constructs, generating the 293T-FVIII-FL/P140K and 293T-eGFP/P140K cell lines. In 293T-FVIII-FL/P140K cells, FVIII and P140K mRNAs levels were 4,410 (±931.7)- and 295,400 (±75,769)-fold higher than in virgin cells. In 293T-eGFP/P140K cells, the eGFP and P140K mRNAs levels were 1,501,000 (±493,700)- and 308,000 (±139,300)-fold higher than in virgin cells. The amount of FVIII-FL was 0.2 IU/mL and 45 ng/mL FVIII cells or 4.4 IU/μg protein. These data demonstrate the efficacy of the bicistronic retroviral vector expressing FVIII-FL and MGMT(P140K), showing that it could be used for producing the FVIII...Continue Reading
References
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J J TooleR J Kaufman
May 20, 1988·Cell·B Furie, B C Furie
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·S N CohenL Hsu
Aug 1, 1996·Molecular and Cellular Biology·F J FallauxA J van Der Eb
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J S ReeseS L Gerson
Dec 5, 1998·American Journal of Hematology·J M SoucieD Jackson
May 9, 2001·Nucleic Acids Research·M W Pfaffl
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·T V PestovaC U Hellen
Mar 29, 2003·Blood·Derek A PersonsBrian P Sorrentino
Jun 21, 2003·Blood·Alessandro GringeriUNKNOWN COCIS Study Group
Jan 1, 1993·Biotechnology Advances·F ManningR O'Kennedy
Nov 18, 2003·The Journal of Clinical Investigation·Steven P ZielskeStanton L Gerson
Dec 24, 2003·Seminars in Hematology·Marilyn J Manco-Johnson
May 4, 2004·Methods : a Companion to Methods in Enzymology·Brian DalbyValentina C Ciccarone
Jun 24, 2004·Thrombosis and Haemostasis·Sven BeckerTorsten Tonn
Oct 21, 2004·Blood·Tobias NeffHans-Peter Kiem
Dec 1, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·A A AshraniN S Key
Mar 5, 2005·Archives of Virology·H WangZ H Yuan
Jun 11, 2005·Journal of Thrombosis and Haemostasis : JTH·N BovenschenK Mertens
Sep 17, 2005·Blood·Jenny GoudemandUNKNOWN FVIII-LFB and Recombinant FVIII study groups
Dec 13, 2005·Stem Cells·An Van DammeMarinee K L Chuah
Jan 25, 2006·Molecular Cancer Therapeutics·Aparecida Maria FontesStanton L Gerson
Jan 28, 2006·Blood·André LarochellePeiman Hematti
Nov 28, 2007·Biotechnology Journal·Theo Dingermann
May 2, 2008·Thrombosis and Haemostasis·Steven W Pipe
Jun 25, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·S W PipeD Lillicrap
Aug 7, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alex H ChangMichel Sadelain
Feb 20, 2009·Biotechnology Journal·Leopold GrillbergerManfred Reiter
Apr 15, 2009·Blood·Huifen ZhaoDerek A Persons
May 29, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·S W Pipe
Jun 17, 2010·The Journal of Clinical Investigation·Brian C BeardHans-Peter Kiem
Nov 19, 2010·Expert Review of Hematology·Rodney M Camire
Dec 17, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Satoshi YokoyamaNigel Heaton
Sep 17, 2011·Journal of Thrombosis and Haemostasis : JTH·S W PipeW H Velander